Some HIGHLIGHTS for this weekend's NHAM NHAM Congress 2024 !!! #CardioX #CardioTwitter #NHAM2024

Walk after a meeting today Newcastle University campus -beautiful ☀️

“Different coronary artery disease patterns: lessons from Women” 👩🏻‍⚕️🩷

It was truly an honor to speak on Spontaneous Coronary Artery Dissection (SCAD) in this great session.

Thank you, Prof Professor Vijay Kunadian for inspiring us!

Rita Calé Eduardo Infante de Oliveira Elisabete Jorge

Thank you Professor Vijay Kunadian for the message. Good insights for a better world. Not everything needs to be polarized in this world!

Review: The role of physiology in the contemporary management of coronary artery disease bit.ly/3uZoh1O

Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis. Read more in #EHJ
#CardioTwitter European Society of Cardiology European Society of Cardiology Journals #metaanalysis Professor Vijay Kunadian
academic.oup.com/eurheartj/adva…

⚡️Just published⚡️
❤️‍🔥Cardiovascular disease lead cause of mortality in older adults
❤️‍🔥Read here our individual patient meta-analysis from Italy, Spain, UK, Norway, Sweden-invasive vs conservative care of NSTEACS in older adults Geir Hirlekar Abdulla A. Damluji, MD, PhD
academic.oup.com/eurheartj/adva…

5 points from associated editorial by my friend and colleague Professor Vijay Kunadian on FULL REVASC: NEJM

🥸Summary

👇👇👇

Original Article: FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction (FULL REVASC) nej.md/3xj5b7u

Editorial: Role of Physiology in the Management of Nonculprit Lesions in Acute Coronary Syndrome nej.md/3PPZQLo

American College of Cardiology #ACC24

Is coronary slow-flow a reliable angiographic surrogate for wire-based physiology testing in INOCA? To be presented at #ACC24 and published simultaneously: ahajournals.org/doi/10.1161/CI… Nathaniel Smilowitz Anais Hausvater #AHAJournals

Presented at #ACC24 :

FULL REVASC: In a registry-based trial, FFR-guided PCI of nonculprit lesions did not result in a lower risk of a composite of death from any cause, myocardial infarction, or unplanned revascularization than culprit-lesion-only PCI. nej.md/3xj5b7u

#ACC2024
#FULLREVASC trial
💥In ACS and multivessel disease, Culprit only PCI vs. FFR guided non-culprit PCI
💥Read my editorial ⬇️ on how this trial impacts clinical practice NEJM

FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction | New England Journal of Medicine nejm.org/doi/full/10.10…

Role of Physiology in the Management of Nonculprit Lesions in Acute Coronary Syndrome | New England Journal of Medicine #ACC2024 nejm.org/doi/full/10.10…

A long-waited PREVENT trial is now presented at LBCT-V #ACC2024
🇰🇷From the inception of trial to completion of trial took a decade.
✅1,606 pts with intracoronary imaging-detected “Vulnerable Plaque” randomized 1:1 to (1) Preventive PCI vs (2) OMT alone.
✅Prevent PCI…

Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial - The Lancet thelancet.com/journals/lance…

Transcatheter or Surgical Treatment of Aortic-Valve Stenosis | New England Journal of Medicine nejm.org/doi/full/10.10…

Presented today at #ACC24 :

A randomized trial that enrolled patients with severe aortic stenosis at low or intermediate surgical risk showed that TAVI was noninferior to SAVR at 1 year. Read the full DEDICATE-DZHK6 trial results: nej.md/3TLx8MT

In the SMART trial of TAVR in patients with a small aortic annulus, a self-expanding valve was noninferior to a balloon-expandable valve for clinical outcomes and was superior for bioprosthetic-valve dysfunction through 12 months. Full results: nej.md/49p7VO7

#ACC24

Original Article: Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes (STEP-HFpEF DM) nej.md/3TPKpUC

American College of Cardiology #ACC24